{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:01Z","timestamp":1790649781877,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":398,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES020700"],"award-info":[{"award-number":["ES020700"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01\u2010HC\u201025195"],"award-info":[{"award-number":["N01\u2010HC\u201025195"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268201500001I"],"award-info":[{"award-number":["HHSN268201500001I"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1111\/jth.15468","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T13:26:02Z","timestamp":1626528362000},"page":"2559-2571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Quantile\u2010specific heritability of plasminogen activator inhibitor type\u20101 (PAI\u20101, aka SERPINE1) and other hemostatic factors"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4872-4556","authenticated-orcid":false,"given":"Paul T.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15468_bb0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V69.2.381.381","article-title":"Plasminogen activator inhibitors","volume":"69","author":"Sprengers","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.15468_bb0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1160\/TH03-08-0546","article-title":"Plasminogen activator inhibitor\u2010type 1: its plasma determinants and relation with cardiovascular risk","volume":"91","author":"Hoekstra","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15468_bb0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00365518509155267","article-title":"The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast\u2010acting inhibitor of tissue\u2010type plasminogen activator after trauma","volume":"45","author":"Kluft","year":"1985","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/jth.15468_bb0025","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1538-7836.2006.01990.x","article-title":"Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G\/5G polymorphism of PAI\u20101 gene","volume":"4","author":"Mlynarska","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15468_bb0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","article-title":"Seven haemostatic gene polymorphisms in coronary disease: meta\u2010analysis of 66,155 cases and 91,307 controls","volume":"367","author":"Ye","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/jth.15468_bb0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MBC.0b013e3281ec4eee","article-title":"Plasminogen activator inhibitor\u20101 4G\/5G polymorphism and risk of ischemic stroke: a meta\u2010analysis","volume":"18","author":"Tsantes","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.15468_bb0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH06-12-0745","article-title":"Association between the plasminogen activator inhibitor\u20101 4G\/5G polymorphism and venous thrombosis: a meta\u2010analysis","volume":"97","author":"Tsantes","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15468_bb0045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/1520-7560(200005\/06)16:3<192::AID-DMRR114>3.0.CO;2-G","article-title":"Relationship between plasma plasminogen activator inhibitor\u20101 and insulin resistance","volume":"16","author":"Bastard","year":"2000","journal-title":"Diabet Metab Res Rev"},{"key":"10.1111\/jth.15468_bb0050","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1055\/s-0037-1616045","article-title":"Role of the 4G\/5G polymorphism of PaI\u20101 gene promoter on PaI\u20101 levels in obese patients: influence of fat distribution and insulin\u2010resistance","volume":"86","author":"Sartori","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15468_bb0055","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1161\/01.CIR.94.9.2057","article-title":"Fibrinolytic factors and the risk for myocardial infarction or sudden death in patients with angina pectoris","volume":"94","author":"Juhan\u2010Vague","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/jth.15468_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000083032","article-title":"Genetic determination of acute phase reactant levels: the strong heart study","volume":"58","author":"Best","year":"2004","journal-title":"Hum Hered"},{"key":"10.1111\/jth.15468_bb0065","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/hq0302.104906","article-title":"Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability","volume":"22","author":"Freeman","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15468_bb0070","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.ATV.18.10.1559","article-title":"Segregation analysis of plasminogen activator inhibitor\u20101 and fibrinogen levels in the NHLBI family heart study","volume":"18","author":"Pankow","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15468_bb0075","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1161\/01.ATV.17.11.2776","article-title":"Moderate genetic influences on plasma levels of plasminogen activator inhibitor\u20101 and evidence of genetic and environmental influences shared by plasminogen activator inhibitor\u20101, triglycerides, and body mass index","volume":"17","author":"Hong","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15468_bb0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1160\/TH04-01-0001","article-title":"Genetic and environmental influences on the fibrinolytic system: a twin study","volume":"92","author":"Peetz","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15468_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(00)03541-8","article-title":"The genetics of haemostasis: a twin study","volume":"357","author":"de Lange","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/jth.15468_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.ATV.19.2.316","article-title":"Determinants of plasma levels of plasminogen activator inhibitor\u20101: a study of normotensive twins","volume":"19","author":"Cesari","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15468_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1257\/jep.15.4.143","article-title":"Quantile regression. J","volume":"15","author":"Koenker","year":"2001","journal-title":"Economic Perspectives"},{"key":"10.1111\/jth.15468_bb0100","first-page":"19","article-title":"Quantile regression with bootstrapped standard errors","volume":"9","author":"Gould","year":"1992","journal-title":"Stata Technical Bulletin"},{"key":"10.1111\/jth.15468_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136379","article-title":"Genetics of plasminogen activator inhibitor\u20101 (PAI\u20101) in a Ghanaian population","volume":"10","author":"White","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/jth.15468_bb0110","article-title":"Quantile\u2010specific heritability of total cholesterol and its pharmacogenetic and nutrigenetic implications","author":"Williams","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1111\/jth.15468_bb0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jacl.2020.05.099","article-title":"Quantile\u2010specific heritability of high\u2010density lipoproteins with implications for precision medicine","volume":"14","author":"Williams","year":"2020","journal-title":"J Clin Lipid"},{"key":"10.1111\/jth.15468_bb0120","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1038\/s41598-020-60965-9","article-title":"Gene\u2010environment interactions due to quantile\u2010specific heritability of triglyceride and VLDL concentrations","volume":"10","author":"Williams","year":"2020","journal-title":"Sci Rep"},{"key":"10.1111\/jth.15468_bb0125","doi-asserted-by":"crossref","first-page":"22152","DOI":"10.1038\/s41598-020-79116-1","article-title":"Quantile\u2010specific heritability of sibling leptin concentrations and its implications for gene\u2010environment interactions","volume":"10","author":"Williams","year":"2020","journal-title":"Sci Rep"},{"key":"10.1111\/jth.15468_bb0130","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10099","article-title":"Quantile\u2010dependent expressivity of plasma adiponectin concentrations may explain its sex\u2010specific heritability, gene\u2010environment interactions, and genotype\u2010specific response to postprandial lipemia","volume":"8","author":"Williams","year":"2020","journal-title":"PeerJ"},{"key":"10.1111\/jth.15468_bb0135","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10914","article-title":"Quantile\u2010dependent expressivity of serum C\u2010reactive protein concentrations in family sets","volume":"9","author":"Williams","year":"2021","journal-title":"PeerJ"},{"key":"10.1111\/jth.15468_bb0140","article-title":"Quantile\u2010specific penetrance of genes affecting lipoproteins, adiposity and height","volume":"7","author":"Williams","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/jth.15468_bb0145","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/s41366-020-0636-1","article-title":"Quantile\u2010dependent heritability of computed tomography, dual\u2010energy x\u2010ray absorptiometry, anthropometric, and bioelectrical measures of adiposity","volume":"44","author":"Williams","year":"2020","journal-title":"Int J Obesity"},{"key":"10.1111\/jth.15468_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10519-019-09989-0","article-title":"Quantile\u2010specific heritability may account for gene\u2010environment interactions involving coffee consumption","volume":"50","author":"Williams","year":"2020","journal-title":"Behav Genet"},{"issue":"50","key":"10.1111\/jth.15468_bb0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10519-020-10005-z","article-title":"Quantile\u2010specific heritability of intakes of alcohol but not other macronutrients","volume":"2020","author":"Williams","year":"2020","journal-title":"Behav Genet"},{"key":"10.1111\/jth.15468_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229495","article-title":"Quantile\u2010dependent expressivity of postprandial lipemia","volume":"15","author":"Williams","year":"2020","journal-title":"PLoS One"},{"key":"10.1111\/jth.15468_bb0165","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9145","article-title":"Spirometric traits show quantile\u2010dependent heritability, which may contribute to their gene\u2010environment interactions with smoking and pollution","volume":"8","author":"Williams","year":"2020","journal-title":"PeerJ"},{"key":"10.1111\/jth.15468_bb0170","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1182\/blood-2012-06-436188","article-title":"Genome\u2010wide association study for circulating levels of PAI\u20101 provides novel insights into its regulation","volume":"120","author":"Huang","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.15468_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a112813","article-title":"An investigation of coronary heart disease in families. The Framingham offspring study","volume":"110","author":"Kannel","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1111\/jth.15468_bb0180","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/aje\/kwm021","article-title":"The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination","volume":"165","author":"Splansky","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1111\/jth.15468_bb0185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10641960902822468","article-title":"Plasminogen activator inhibitor\u20101 and the circadian clock in metabolic disorders","volume":"31","author":"Oishi","year":"2009","journal-title":"Clin Exp Hypertens"},{"key":"10.1111\/jth.15468_bb0190","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/CIRCULATIONAHA.109.929661","article-title":"Multimarker approach for the prediction of heart failure incidence in the community","volume":"122","author":"Velagaleti","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/jth.15468_bb0195","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.V71.1.220.220","article-title":"Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody\u2010based enzyme\u2010linked immunosorbent assay","volume":"71","author":"Declerck","year":"1988","journal-title":"Blood"},{"key":"10.1111\/jth.15468_bb0200","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/clinchem\/32.12.2160","article-title":"Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme\u2010linked immunosorbent assay","volume":"32","author":"R\u00e5nby","year":"1986","journal-title":"Clin Chem"},{"key":"10.1111\/jth.15468_bb0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.thromres.2016.02.002","article-title":"Plasminogen activator inhibitor and the risk of cardiovascular disease: the Framingham Heart Study","volume":"140","author":"Tofler","year":"2016","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15468_bb0210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.ATV.20.2.593","article-title":"Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study","volume":"20","author":"Feng","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15468_bb0215","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/01.CIR.83.5.1630","article-title":"Correlation of circulation von Willebrand factor levels with cardiovascular hemodynamics","volume":"83","author":"Penny","year":"1991","journal-title":"Circulation"},{"key":"10.1111\/jth.15468_bb0220","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1073\/pnas.78.5.2664","article-title":"Sibling and parent\u2010offspring correlation estimation with variable family size","volume":"78","author":"Karlin","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15468_bb0225","series-title":"Introduction to Quantitative Genetics","author":"Falconer","year":"1996"},{"key":"10.1111\/jth.15468_bb0230","series-title":"Statistical Principles in Experimental Design","author":"Winer","year":"1991"},{"key":"10.1111\/jth.15468_bb0235","first-page":"122","article-title":"PAI\u20101 promoter 4G\/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects","volume":"111","author":"Segu\u00ed","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15468_bb0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/107602960300900405","article-title":"The PAI\u20101 gene 4G\/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia","volume":"9","author":"Sartori","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.15468_bb0245","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1017\/S0007114507831710","article-title":"The \u2010675 4G\/5G polymorphism at the plasminogen activator inhibitor 1 (PAI\u20101) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption","volume":"99","author":"P\u00e9rez\u2010Mart\u00ednez","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1111\/jth.15468_bb0250","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0037-1613304","article-title":"Diurnal variation in PAI\u20101 activity predominantly confined to the 4G\u2010allele of the PAI\u20101 gene","volume":"88","author":"Hoekstra","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15468_bb0255","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor (PAI\u20101) gene respond differently to interleukin\u20101 in hepG2 cell","volume":"268","author":"Dawson","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15468_bb0260","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0268-9499(95)80015-8","article-title":"Structure of plasminogen activator inhibitor\u20101 (PAI\u20101) and its function in fibrinolysis: an update","volume":"9","author":"van Meijer","year":"1995","journal-title":"Fibrinolysis"},{"key":"10.1111\/jth.15468_bb0265","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.ATV.17.5.851","article-title":"Five frequent polymorphisms of the PAI\u20101 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population","volume":"17","author":"Henry","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15468_bb0270","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0037-1614516","article-title":"Plasminogen activator inhibitor\u20101 (PAI\u20101) promoter 4G\/5G genotype and increased PAI\u20101 circulating levels in postmenopausal women with coronary artery disease","volume":"81","author":"Grancha","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15468_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000511421","article-title":"Quantile\u2010dependent expressivity and gene\u2010lifestyle interactions involving high\u2010density lipoprotein cholesterol","volume":"14","author":"Williams","year":"2021","journal-title":"Lifestyle Genom"},{"key":"10.1111\/jth.15468_bb0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00264-005-0067-6","article-title":"Changes in coagulation and fibrinolysis of post\u2010SARS osteonecrosis in a Chinese population","volume":"30","author":"Sun","year":"2006","journal-title":"Int Orthop"},{"key":"10.1111\/jth.15468_bb0285","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00590-013-1223-0","article-title":"Relationship between post\u2010SARS osteonecrosis and PAI\u20101 4G\/5G gene polymorphisms","volume":"24","author":"Sun","year":"2014","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"10.1111\/jth.15468_bb0290","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.steroids.2013.01.004","article-title":"Genetic risk factors for glucocorticoid\u2010induced osteonecrosis: a meta\u2010analysis","volume":"78","author":"Gong","year":"2013","journal-title":"Steroids"},{"key":"10.1111\/jth.15468_bb0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00003086-199909000-00017","article-title":"The plasminogen activator inhibitor\u20101 gene, hypofibrinolysis, and osteonecrosis","volume":"366","author":"Glueck","year":"1999","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/jth.15468_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-200105000-00004","article-title":"Hypofibrinolysis, thrombophilia, osteonecrosis","volume":"386","author":"Glueck","year":"2001","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/jth.15468_bb0305","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(99)02220-5","article-title":"4G\/5G promoter polymorphism in the plasminogen\u2010activator\u2010inhibitor\u20101 gene and outcome of meningococcal disease. Meningococcal Research Group","volume":"354","author":"Hermans","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/jth.15468_bb0310","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/infdis\/173.5.1148","article-title":"The relationship between plasminogen activator inhibitor\u20101 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock","volume":"173","author":"Kornelisse","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1111\/jth.15468_bb0315","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1055\/s-0037-1615105","article-title":"The 4G\/5G sequence polymorphism in the promoter of plasminogen activator inhibitor\u20101 (PAI\u20101) gene: relationship to plasma PAI\u20101 level in venous thromboembolism","volume":"79","author":"Stegnar","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15468_bb0320","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11239-009-0398-z","article-title":"Reduced carriership of 4G allele of plasminogen activator inhibitor\u20101 4G\/5G polymorphism in very young survivors of myocardial infarction","volume":"29","author":"Rallidis","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.15468_bb0325","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/diab.46.5.860","article-title":"Production of plasminogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease","volume":"46","author":"Alessi","year":"1997","journal-title":"Diabetes"},{"key":"10.1111\/jth.15468_bb0330","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nm0796-800","article-title":"Enhanced expression of PAI\u20101 in visceral fat: possible contributor to vascular disease in obesity","volume":"2","author":"Shimomura","year":"1996","journal-title":"Nature Med"},{"key":"10.1111\/jth.15468_bb0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s001250050868","article-title":"Adipose tissue secretion of plasminogen activator inhibitor\u20101 in non\u2010obese and obese individuals","volume":"41","author":"Eriksson","year":"1998","journal-title":"Diabetologia"},{"key":"10.1111\/jth.15468_bb0340","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.ATV.21.6.1071","article-title":"Interactive effect of PAI\u20101 4G\/5G genotype and salt intake on PAI\u20101 antigen","volume":"21","author":"Brown","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15468_bb0345","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12020-009-9255-2","article-title":"The plasminogen activator inhibitor\u20101 (PAI\u20101) gene \u2010844 A\/G and \u2010675 4G\/5G promoter polymorphism significantly influences plasma PAI\u20101 levels in women with polycystic ovary syndrome","volume":"36","author":"Lin","year":"2009","journal-title":"Endocrine"},{"key":"10.1111\/jth.15468_bb0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0021-9150(98)00108-7","article-title":"Increased PAI activity and PAI\u20101 antigen occurring with an oral fat load: associations with PAI\u20101 genotype and plasma active TGF\u2010beta levels","volume":"140","author":"Byrne","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1111\/jth.15468_bb0355","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/ajcn\/79.4.577","article-title":"Postprandial variations in fibrinolytic activity in middle\u2010aged men are modulated by plasminogen activator inhibitor I 4G\u2013675\/5G genotype but not by the fat content of a meal","volume":"79","author":"Sanders","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/jth.15468_bb0360","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.18.1.20","article-title":"Very\u2010low\u2010density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor\u20101 gene implicated in the impaired fibrinolysis of hypertriglyceridemia","volume":"8","author":"Eriksson","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15468_bb0365","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/diab.44.1.37","article-title":"Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene","volume":"44","author":"Panahloo","year":"1995","journal-title":"Diabetes"},{"key":"10.1111\/jth.15468_bb0370","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.96.1.19","article-title":"Morning hypercoagulability and hypofibrinolysis: diurnal variations in circulating activated factor VII, prothrombin fragment F1\u03b22, and plasmin\u2010plasmin inhibitor complex","volume":"96","author":"Kapiotis","year":"1997","journal-title":"Circulation"},{"key":"10.1111\/jth.15468_bb0375","doi-asserted-by":"crossref","first-page":"36847","DOI":"10.1074\/jbc.C000629200","article-title":"CLIF, a novel cycle\u2010like factor, regulates the circadian oscillation of plasminogen activator inhibitor\u20101 gene expression","volume":"275","author":"Maemura","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15468_bb0380","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1182\/blood-2002-07-2181","article-title":"The 4G5G polymorphism in the gene for PAI\u20101 and the circadian oscillation of plasma PAI\u20101","volume":"101","author":"van der Bom","year":"2003","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15468","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15468","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622021626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622021626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:52:02Z","timestamp":1774860722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622021626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1538783622021626"],"URL":"https:\/\/doi.org\/10.1111\/jth.15468","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantile\u2010specific heritability of plasminogen activator inhibitor type\u20101 (PAI\u20101, aka SERPINE1) and other hemostatic factors","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 This article is a U.S. Government work and is in the public domain in the USA. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}